Eli Lilly & Co. vs Solventum Corporation
LLY vs SOLV — side-by-side comparison from reported financials. LLY leads 8, SOLV leads 2 of 10 comparable metrics.
Eli Lilly & Co.
LLY · Healthcare
$1 177.20+0.65%Solid
Solventum Corporation
SOLV · Healthcare
$87.88+1.70%Strained
| Metric | LLY | SOLV |
|---|---|---|
| Price | $1 177.20 | $87.88 |
| Market cap | $1.05T | $15.0B |
| Revenue (TTM) | $79.7B | $8.31B |
| Revenue growth | +31.7% | +0.8% |
| Net margin | 33.5% | 17.3% |
| Free cash flow | $18.2B | -$118M |
| Net cash (debt) | ($35.2B) | ($4.16B) |
| 1-year price return | +37.6% | +22.4% |
| P/E | 41.6 | 10.4 |
| P/E vs own history (cheap-side %) | 88% | 66% |
| Dividend yield | 0.52% | — |
| Return on equity | 93% | 29% |
| Altman Z-score | 7.10 | — |
| CV checks passed | 11 of 11 | 6 of 11 |
| Employees | 50,000 | 20,000 |
Full résumé-style profiles: LLY CV · SOLV CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.